Abstract Elevated plasma total homocysteine (Hcy) level is associated with an increased risk of Alzheimer's disease (AD). During transsulfuration pathways, Hcy is metabolized into hydrogen sulfide (H 2 S), which is a synaptic modulator, as well as a neuro-protective agent. However, the role of hydrogen sulfide, as well as N-methyl-D-aspartate receptor (NMDAR) activation, in hyperhomocysteinemia (HHcy) induced bloodbrain barrier (BBB) disruption and synaptic dysfunction, leading to AD pathology is not clear. Therefore, we hypothesized that the inhibition of neuronal NMDA-R by H 2 S and MK801 mitigate the Hcy-induced BBB disruption and synapse dysfunction, in part by decreasing neuronal matrix degradation. Hcy intracerebral (IC) treatment significantly impaired cerebral blood flow (CBF), and cerebral circulation and memory function. Hcy treatment also decreases the expression of cystathionine-β-synthase (CBS) and cystathionine-γ-lyase (CSE) in the brain along with increased expression of NMDA-R (NR1) and synaptosomal Ca 2+ indicating excitotoxicity. Additionally, we found that Hcy treatment increased protein and mRNA expression of intracellular adhesion molecule 1 (ICAM-1), matrix metalloproteinase (MMP)-2, and MMP-9 and also increased MMP-2 and MMP-9 activity in the brain. The increased expression of ICAM-1, glial fibrillary acidic protein (GFAP), and the decreased expression of vascular endothelial (VE)-cadherin and claudin-5 indicates BBB disruption and vascular inflammation. Moreover, we also found decreased expression of microtubule-associated protein 2 (MAP-2), postsynaptic density protein 95 (PSD-95), synapse-associated protein 97 (SAP-97), synaptosomalassociated protein 25 (SNAP-25), synaptophysin, and brainderived neurotrophic factor (BDNF) showing synapse dysfunction in the hippocampus. Furthermore, NaHS and MK801 treatment ameliorates BBB disruption, CBF, and synapse functions in the mice brain. These results demonstrate a neuro-protective effect of H 2 S over Hcy-induced cerebrovascular pathology through the NMDA receptor. Our present study clearly signifies the therapeutic ramifications of H 2 S for cerebrovascular diseases such as Alzheimer's disease.
Introduction
Homocysteine (Hcy) is a toxic thiol-containing molecule, also considered an excitatory amino acid, which markedly enhances the vulnerability of neuronal cells through an excitotoxicity mechanism. An elevated plasma homocysteine level, known as hyperhomocystemia (HHcy), was found to be associated with an increased risk factor for strokes [1] , vascular dementia, and Alzheimer's disease (AD) [2, 3] . HHcy levels also predict cognitive decline in healthy elderly patients [4, 5] . However, not all studies confirm a relationship between Hcy and cognition [6, 7] . HHcy's vascular complications and its impact on the hippocampus have not yet been studied. Intriguingly, it has been reported that more than 40 % of Alzheimer's disease patients are associated with high plasma Hcy levels, which is linked to a more rapid neural atrophy than those with normal levels of Hcy. Therefore, preventing the Hcy induced neurotoxicity may be a novel therapeutic strategy for AD. However, the underlying mechanisms by which Hcy creates an AD-like pathology by means of blood-brain barrier (BBB) disruption and altered synapse function are not fully explored (Table 1) .
Hydrogen sulfide (H 2 S) is an integral endogenous signaling gasotransmitter molecule. In the brain, H 2 S is produced endogenously by the metabolism of the amino acid cysteine (Cys) by the action of cystathionine-β-synthase (CBS) and cystathionine-γ-lyase (CSE). In the mitochondria, H 2 S is produced by the action of 3-mercaptopyruvate sulfurtransferase enzyme (3-MST). Hydrogen sulfide plays an important role in vasorelaxation, inflammation, cell angiogenesis, hippocampal memory formation, and cellular bioenergetics. In addition, it was observed that H 2 S levels were decreased, and Hcy levels were elevated in AD brains [8] . Likewise, it was noted that the physiological concentration of H 2 S specifically enhances the NMDA receptor mediated response and facilitates hippocampal long-term potentiation (LTP), which is extensively associated with proper learning and memory function.
N-Methyl-D-aspartate receptors (NMDARs) are glutamategated ion channels that are highly permeable to calcium (Ca 2+ ), and the Ca 2+ influx through NMDARs is essential for synaptogenesis, synaptic remodeling, and long-lasting changes in synaptic efficacy [9] . The NMDAR is involved in cellular mechanisms for learning and memory function and also plays a role in a wide array of other biological processes crucial for brain development and function [10, 11] .
Matrix metalloproteinases (MMPs) are a group of zincdependent proteolytic enzymes known to be involved in the cleaving of extracellular matrix (ECM) components and pericellular proteins. Among the MMPs, MMP-2, MMP-3, and MMP-9 are highly expressed in brain tissues and, like the NMDAR, are associated with various brain functions such as brain development, synaptogenesis, synaptic plasticity, learning and memory, neuron-glia interactions, neuronal injury, and are linked to neuropsychiatric disorders [12, 13] . MMP-9 has been extensively characterized and is required for the creation of LTP and plays a vital role in learning and memory through interactions with NMDAR signaling [14, 15] . The activation of MMPs leads to the degradation of tight junction (TJ) proteins and consequently causes BBB disruption by degrading the ECM of cerebral blood vessels along with several types of adhesion molecules such as intracellular adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM). As expected the BBB damage has a critical role in cerebral pathophysiology and disease progression in the central nervous system [16] . Although MMP-9 role is well known in the regulation of synapse function and plasticity [15, 17] , its association with HHcy-induced functional remodeling of synapses remains uncertain.
Recently, we have shown that administration of Hcy into the mice brain affects memory function [18] and have shown that H 2 S seems to protect against Hcy-induced neurotoxicity, but the underlying pathology was unclear. In our present study, we investigated how Hcy induced BBB disruption and altered synapse function. We also scrutinized the relationship among HHcy, the NMDAR, and H 2 S as its link to ADlike pathology remains postulated.
Methodology Antibodies and Reagents
Homocysteine, NaHS, and MK801 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies MMP-9, MMP-2, NR1, brain-derived neurotrophic factor (BDNF), vascular endothelial (VE)-cadherin, microtubule-associated protein 2 (MAP-2), claudin-5, ICAM-1, VCAM-1, postsynaptic density Table 1 Sequence of primers of the different genes and their product length   Primers  Forward sequence  Reverse sequence  Base pair   PSD95  5′-CAAGACCGACATCACAGGA-3′  5′-ACGGCAAGGGCGAAT-3′  470   SNAP25  5′-GCAGGGTAACAAACGATGCC-3  5′-CTTCCCAGCATCTTTGTTGC-3′  211  Synaptophysin  5′-TGCAGAACAAGTACCGAGAG-3′  5′-CTGTCTCCTTAAACACGAACC-3′  297   MAP-2  5′-CCACCTGAGATTAAGGATCA-3′  5′-GGCTTACTTTGCTTCTCTGA-3′  482   MMP-2  5′ -GCACTCTGGAGCGAGGATAC-3′  5′-GCCCTCCTAAGCCAGTCTCT-3′  362  MMP-9  5′-AAGGCAAACCCTGTGTGTTC-3′  5′-GTGGTTCAGTT GTGGTGGTG-3′  385   ICAM-1  5′-GTGGCGGGAAAGTTCCTG-3′  5′-CGTCTTGCAGGTCATCTTAGGAG-3′  171  Claudin-5  5′-GGCACTCTTTGTTACCTTGACC-3′  5′-CAGCTCGTACTTCTGTGACACC-3′.  2 0 2   GFAP  5′-TCCTGGAACAGCAAAACAAG-3′  5′-CAGCCTCAGGTTGGTTCAT-3′  256   VE-Cadherin  5′-AACTTCCCCTTCTTCACCC-3′  5′-AAAGGCTGCTGGAAAATG-3′  512  NR1  5′-GAATGATGGGCGAGCTACTCA-3′  5′-ACGCTCATTGTTGATGGTCAGT-3′  71   BDNF  5′-GGGTCACAGCGGCAGATAAA -3′  5′-GCCTTTGGATACCGGGACTT -3′  86  GAPDH  5′-TGAAGGTCGGTGTGAACGGATTTGGC-3′  5′-CATGTAGGCCATGAGGTCCACCAC-3′  983 protein 95 (PSD-95), and synapse-associated protein 97 (SAP-97) were purchased from ABCAM (Cambridge, MA, USA 
Drug Preparation and Administration
Hcy was dissolved in freshly prepared artificial cerebrospinal fluid (aCSF; 147 mM NaCl, 2.9 mM KCl, 1.6 mM MgCl 2 ⋅6H 2 O, 1.7 mM CaCl 2, and 2.2 mM dextrose dissolved in distilled water) used as a vehicle for intracerebral administration of Hcy. In the Hcy group, a single administration of Hcy (0.5 μM/μl) was given intracerebrally (IC) in mice brain. Sodium hydrogen sulfide (NaHS, a H 2 S donor) and MK801 were dissolved in 0.9 % normal saline. Hcy (IC) injected mice were treated with NaHS (30 μM kg −1 day −1 i.p.) and MK801
(0.05 mg kg −1 day i.p) for 7 days through the intraperitoneal route. NaHS and MK801 doses were used as described earlier [18, 19] . Animals of the control group received aCSF intracerebral (IC) injections. Biochemical, behavioral, molecular, and immunohistochemical analyses were done 24 h after the last NaHS treatment or its vehicle injection in the separate groups.
Intracerebral Injection of Hcy
Mice were anesthetized with tribromoethanol anesthetic solution [TB; 2.5 g, 2,2,2 tribromoethanol (TBE); 5 ml 2-methyl-2-butanol (tertiary amyl alcohol) 200 ml distilled water, neutral pH] (200 μg/g, i.p). A 27-gauge hypodermic needle attached to a 100-μl Hamilton syringe was inserted (2.5 mM depth) perpendicularly through the skull into the brain. Hcy (0.5 μM/μl), dissolved in freshly prepared aCSF, was administered slowly through IC route. The site of injection was 2 mm from either side of the midline on a line drawn through the anterior base of the ears. We injected Hcy only one side from the midline as previously reported [18] . The syringe was left in the place for a further 2 min for proper diffusion of Hcy.
Experimental Design and Drug Administration
The mice (n=5 for each study) were grouped as:
aCSF: mice injected IC with aCSF once and treated with v e h i c l e s o f N a H S a n d M 
Novel Object Recognition Test
Novel object recognition is a validated and widely used test for assessing recognition memory [20] . Mice were placed individually in a testing chamber with beige walls for a 5-min habituation interval and returned to their home cage. Thirty minutes later, mice were placed in the testing chamber for 10 min with two identical objects (acquisition session). Mice were returned to home cages and, 1 day later, placed back into the testing chamber in the presence of one of the original objects and one novel object (recognition session) for 5 min. The chambers and objects were cleaned with ethanol between trials. Exploratory behavior was defined as sniffing, touching, and directing attention to the object. Expected normal behavior would be, with a short delay between acquisition and retention trials, that the animal explores the novel object for a longer period of time than the familiar object. For the acquisition session, the recognition index (RI) was calculated as time exploring one of the objects over the time exploring both objects. For the recognition session, the RI was calculated as time exploring the novel object over the time exploring both the familiar and novel object. Discrimination index (DI) is an index of discrimination between object and was calculated by the method described by Kamat et al. [18] .
Passive Avoidance Test
The mice were subjected to the passive avoidance test by placing the animal in a compartment with light at an intensity of 8 [scale from 0 to 10 (brightest)] in a computerized shuttle box with a software program PACS 30 monitoring (Columbus Instruments, OH, USA). The light compartment was isolated from the dark compartment by an automated guillotine door.
After an acclimatization period of 30 s, the guillotine door was opened and closed automatically after entry of the mouse into the dark compartment. The subject received a low-intensity foot shock (0.5 mA; 10 s) in the dark compartment. Infrared sensors monitored the transfer of the animal from one compartment to another, which was recorded as transfer latency time (TLT) in seconds. The first trial was for acquisition, and retention was tested in a second trial and third trial given after 24 and 48 h of the first trial. The criteria for learning were taken as an increase in the TLT on retention (second or subsequent) trials as compared to acquisition (first) trial.
Cerebral Blood Flow
Regional cerebral blood flow (CBF) was measured in the different treatment groups of mice to differentiate the blood flow in brain using a laser Doppler scan (Moor Instruments, moor FLPI) to verify reperfusion. Briefly, skin was gently removed from the cranial surface, and cranial window was created by the method described by Lominadze et al. [21] . Furthermore, the cranium was cleaned with alcohol. CBF of the lateral hemisphere (parietal cortex) was continuously monitored with laser Doppler flowmetry. The head of laser fiber was placed on the area of right hemisphere of the brain. The mice CBF was recorded by software and calculated by percentage of CBF index (CBFI)=(CBF of Hcy-injected mice brain/CBF of aCSF-injected mice brain)×100.
Microvascular Observation
Microvasculature in the brain was observed through cranial windows and was captured using a laser Doppler scan (Moor Instruments, moor FLPI). Laser Doppler scans were placed at different areas of the right hemisphere through the cranial window. In brief, cranial window was created with the help of microdriller, and parietal bone was removed carefully to avoid any injury. The open area was regularly flushed with aCSF to prevent from drying. After that, mouse was placed below the Doppler scan to visualize the brain vessel through cranial window.
Hippocampus Tissue Collection and Protein Extraction
The mice were killed with anesthesia at the end of the memory function test. Brain samples were removed quickly after intracardiac perfusion with chilled normal saline and kept on ice-cold PBS immediately. Hippocampal tissue was dissected out by the method of Glowniski and Iversion [22] and used for estimation of biochemical and molecular studies.
Protein Sample Preparation
Hippocampal tissue samples from each group were weighed and homogenized in 1× RIPA buffer (50 mM Tris-HCl, pH 7.4; 1 % NP-40; 0.25 % Na-deoxycholate, 150 mM NaCl; 1 mM EDTA; 1 mM phenylmethylsulfonyl fluoride (PMSF); 1 μg/ml each of aprotinin, leupeptin, and pepstatin; 1 mM Na 3 VO 4 ; 1 mM NaF) containing 1 mM PMSF and 1 μg complete protease inhibitor (Sigma). The homogenate was kept on ice for 30 min and centrifuged (100×g) for 10 min at 4°C, and then, the supernatant was removed and centrifuged a second time (20,000×g for 15 min at 4°C) to remove any remaining debris. Protein levels for all samples were quantified by the Bradford method (Bio-Rad, CA, USA) and stored at −80°C for further use.
RNA Sample Preparation and RT-PCR Analysis
RNA samples from the hippocampal tissues were prepared by the Trizol method. The quantity and quality of RNA was measured using a Nano Drop 1000 spectrophotometer, and the purity of the RNA was determined by A 260 /A 280 ratio. Approximately 2 μg of total RNA was reverse-transcribed using reverse transcriptase (RT) in a 20-μl mixture containing oligo (dT) primer, RNase Inhibitor, dNTP mix, and 5× reaction buffer (Omniscript QIAGEN Inc. Valencia, CA, USA). Reverse transcription PCR (RT-PCR) reaction was performed using a ImProm-II TM Reverse Transcription PCR system kit (Promega Corporation, Madison, WI, USA). Complementary DNA (cDNA) was prepared using 2 μg of the isolated RNA. A reverse transcription program on the DNA Engine S1000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA) was used to make the cDNA. The transcript level of gene expression was determined in the cDNA sample using reverse transcriptase PCR. The PCR mixture (25 μl) contained PCR master mix, 2 μl cDNA, and 40 pMol primer and amplified through stratagene Mx3000p (Agilent Technologies, Santa Clara, CA, USA). The gene expression in all the groups was normalized with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression.
Microvascular Permeability in Brain
Blood flow in the brain microvasculature was measured in anesthetized mice fitted in a stereotaxic apparatus to prevent mechanical damage during drilling. A cranial window was made in the skull using a high-speed microdrill (Fine Surgical Tool). The exposed area was regularly flushed with artificial cerebrospinal fluids. Syringe pumps were fitted with two injections, one containing heparin saline to prevent from clotting and the other with an fluorescein isothiocyanate (FITC) solution. Fluorescein isothiocyanate (300 mg/ml) bound to bovine serum albumin (BSA) (FITC-BSA) was infused (0.2 ml/100 g of body wt) by a syringe pump (Harvard Apparatus) and allowed to circulate for about 5 min [21] . The pial circulation was surveyed to ensure that spontaneous leakage in the observed area would not falsely indicate vascular integrity. Venules were identified by observing the topology of the pial circulation and blood flow direction (vascular diameters increasing in the direction of blood flow). The exposed area was actively observed using in vivo imaging fluorescent microscopy (Olympus, Japan).
Immunohistochemistry
The frozen brain tissues were blocked with blocking solution (5 % BSA in TBS-T) and incubated with a primary antibody at 1:100 dilutions overnight at 4°C. The unbound antibody was washed with TBS, and the sections were then incubated with goat antimouse Alexa Flour 488 and goat antirabbit Taxas Red for 60 min at RT. The slides were further stained with DAPI (1:10, 000) for 10 min, washed, and mounted with antifade mounting media. The images were acquired using a laser scanning confocal microscope (60× objectives, FluoView 1000, Olympus, PA, USA). Total fluorescence intensity in five random fields (for each experiment) was measured with image analysis software (Image-Pro Plus, Media Cybernetics, Rockville, MD, USA).
Western Blotting
Western blot analysis was used for protein expression in the different treatment groups. Briefly, protein was extracted using 1× RIPA buffer. Equal amounts of protein from the brains were separated by sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE). Further, the proteins from the gel were transferred onto PVDF membranes to check their expression (BioRad, Hercules, CA, USA) by wet transfer method. Nonspecific sites of protein on membrane were blocked with 5 % nonfat dry milk in TBS-T (50 mM Tris-HCl, 150 mM NaCl, 0.1 % Tween-20, pH 7.4) for 1 h at room temperature at slow rocking. The membranes were washed with washing buffer (pH 7.6, TBS, 0.1 % Tween 20) three times at 10 min each. The blots were then incubated overnight at 4°C with the appropriate primary antibody prepared in TBS-T solution. The blots were washed with TBS-T (three times, 10 min each) and incubated with appropriate HRPconjugated secondary antibody for 2 h at room temperature. After washing with TBST-T, ECL Plus substrate (Thermo Scientific, Inc.) was applied to the blot for protein expression, and images were captured in the gel documentation system. Relative optical density of protein bands were analyzed using the software Image Lab 3.0. The same membranes were stripped and reprobed with GAPDH as a loading control.
Gelatin Zymography
Brain samples were minced in an ice-cold extraction buffer (1:3w/v) containing 10 mmol/l cacodylic acid, 20 mM ZnCl, 1.5 mM NaN 3 , and 0.01 % Triton X-100 (pH 5.0) and incubated overnight at 4°C with gentle agitation. The homogenate was centrifuged for 15 min at 1500×g, and the supernatant was collected. Fifty grams of the protein was electrophoretically resolved for each sample in 10 % SDS-PAGE containing 0.1 % gelatin as the MMP substrate. Gels were washed in renaturing buffer with one change in between to remove the SDS, rinsed in water, and incubated for at least 48 h in developing buffer at 37°C in a water bath with gentle shaking. Gels were stained with 0.5 % Coomassie brilliant blue for 1 h at room temperature. MMP activity in the gel was detected as white bands against a dark blue background.
Statistical Analysis
The results were expressed as mean ± SEM. Memory functions were analyzed by ANOVA followed by Student's t test. Biochemical and molecular data were analyzed by Student's t test. A p<0.05 was considered to be significant. The data were analyzed using software Graph Pad Prism version X6.
Results

Memory Function by Passive Avoidance Test
Effect of NaHS and MK801 on Hcy-Induced Memory Impairment
A test was performed to assess the memory function in the mice of different groups. We did not find a significant difference in transfer latency time in retention trial of days 1 and 2 as compared to the acquisition trial in Hcy-injected mice. However, treatment with H 2 S donor (NaHS) and NMDA receptor antagonist (MK801) significantly increased the transfer latency time in Hcyinjected mice. Further, we did not observe any alteration in H 2 S and MK801 per se treated group on memory function as compared to aCSF-treated group (Fig. 1a) .
Novel Object Recognition Test
The novel object recognition test was performed for determining memory function in mice. Hcy (IC) treated mice exhibit significantly impaired novel object recognition performance in the simple task relative to wildtype mice exploring the novel object. There was no change in RI in the acquisition trial among the group, but significant changes were observed in the retention trial. Consistent with the lack of net preference between novel and familiar objects, the DI in Hcy-treated mice was reduced with respect in the wild types. NaHS and MK801 treatment led to improved preference between novel and familiar object in Hcy-treated mice (Fig. 1b) .
Effect of NaHS and MK801 on Hcy-Induced Physiological Properties of Microvessel and
Microvascular Density
Angiogenesis is a complex process that involves an appropriate environment of the brain. This environment requires the proper presence of extracellular matrix proteins, proteases, and the occurrence of other cellular events in sequential order. In the Hcy injection group, microvascular density was significantly less after 7 days posttreatment. Treatment with NaHS and MK801 significantly restored microvascular density in Hcyinjected mice brain and indicates the angiogenic properties of NaHS and MK801. Further, we did not observe any change in microvascular density either with MK801, or hydrogen sulfide per se treatments (Fig. 2a) .
Cerebral Blood Flow
CBF, which is necessary for maintenance of the brain function, was assessed in different treatment groups. There was significant decreased blood flow in Hcytreated mice as compared to the aCSF-treated group. Interestingly, the given treatment of hydrogen sulfide and MK801 significantly alleviated blood flow in Hcyinjected mice brain. However, no changes were found in per se treatment with hydrogen sulfide donor and MK801 treatments (Fig. 2b) .
Microvascular Permeability
Typically, a balance occurs between the amounts of plasma going into the tissues from the microvascular capillaries and the amount re-entering the circulatory system from the tissues. When the neuronal tissue is damaged as a result of injury, the lining of the small blood vessels becomes leaky, thereby increasing vessel permeability and disturbing normal brain function. Hcy (IC) injection in mice brain caused an increase in permeability in the microvessels as evidenced by BSA (FITC) leakage when compared to aCSF-injected mice. Interestingly, NaHS and MK801 treatment significantly protected the apparent leakage of BSA (FITC), indicating a vascularprotective effect. There was no significant change in permeability of mice brain with respect to the NaHS and MK801 per se treatments (Fig. 3a, b) .
Effect of NaHS and MK801 on H 2 S Metabolizing Enzyme (CBS and CSE) Expression
CBS and CSE act on substrates Hcy and L-cysteine to produce H 2 S. In cases of excess Hcy, redox stress imbalance occurs and affects CBS and CSE gene expression. We observed a decreased expression of CBS and CSE in the hippocampus of the Hcy-injected mouse brains. Conversely, the expression of CBS and CSE was restored by NaHS and MK801 treatment. However, no changes were found in the expression pattern of CBS and CSE in NaHS and MK801 per se groups (Fig. 4a, b) .
Effect of NaHS and MK801 on Hcy-Induced MMPs Neurophysiological MMP-2 and MMP-9 Expression and Activity
MMP-2 and MMP-9, also called gelatinases A and B, play a vital role in the degradation of the BBB and consequently can cause neuronal impairment in the brain if overstimulated. Hcy (IC) injection led to increased MMP-9 and MMP-2 proteins and messenger RNA (mRNA) expression, respectively, in the hippocampus. Hydrogen sulfide and MK801 significantly mediated the elevation of MMP-9 and MMP-2 expression, whereas the per se treatment with hydrogen sulfide or MK801 did not show any effect on MMP proteins or mRNA expression. The zymography assay showed increased activity of MMP-9 and MMP-2 in Hcy-treated mice brain hippocampus as compared to aCSF group. The treatment with NaHS and MK801 significantly mitigated the expression and activity of MMP-9 and MMP-2 induced by Hcy. No changes were found in the per se treatments of NaHS and MK801 (Fig. 5a-f) . (Fig. 6a-d) .
Immunohistochemistry of ICAM-1 and Claudin-5
Immunohistochemistry assay showed differential expression of ICAM-1 and claudin-5 in Hcy (IC) injected mouse brain. Briefly, we found increased expression of ICAM-1 and decreased expression of claudin-5, which was significantly improved by NaHS and MK801 treatment. No difference was observed with NaHS and MK801 per se treatments ( Fig. 6e  and f) .
Western blotting, mRNA Expression, and Immunohistochemistry of GFAP and VE-Cadherin
Endothelial permeability is synchronized in part by the dynamic opening and closure of cell-to-cell adherens junctions (AJs). Increased vascular permeability affects the function and organization of VE-cadherin and other proteins such as glial fibrillary acidic protein (GFAP). Western blot and PCR analysis showed increased expression of GFAP and decreased expression of VE-cadherin in Hcy-injected mice brain. Additionally, NaHS and MK801 treatment significantly improved the expression of GFAP and VE-cadherin. No alteration was observed with NaHS and MK801 per se treatment. Immunohistochemistry assay also showed altered expression of GFAP and VE-cadherin in Hcy-injected mice brain as compared to aCSF-injected mice brain. Treatment with NaHS and MK801 for 7 days significantly restored their appropriate expression. Moreover, no significant changes were found in GFAP and VE-cadherin expression of NaHS and MK801 per se treatment groups (Fig. 7a-f) .
Effect of NaHS and MK801 on Hcy-Induced Altered Synapse NR1 and BDNF Protein and mRNA Expression
Intracerebral injection of Hcy caused increased expression of NR1 protein and NR1 mRNA and decreased the expression of BDNF protein and BDNF mRNA. In addition to these, per se treatments with both the reagents did not show difference. Further, treatment with NaHS and MK801 treatment significantly restored the protein and mRNA expression of NR1 and BDNF (Fig. 8a-f ).
Synaptosomal Ca 2+ Level
Calcium ions maintain synapse plasticity and regulate synaptic function in neurons. In the present study, Hcy caused an increase in Ca 2+ levels in the synapse preparation, which was normalized in our NaHS and MK801 treatment groups. No considerable changes were observed in MK801 and NaHS treatment (Fig. 9 ).
MAP-2 mRNA and Protein Expression
MAP-2 is found in neuronal dendrites and is involved in microtubule assembly within the brain. Western blot and PCR assay depicts altered protein and mRNA expression of MAP-2 in the hippocampus of Hcy-injected mouse brain in comparison to aCSF-injected mouse brain hippocampus. Likewise, NaHS and MK801 significantly restored MAP-2's expression. The treatments of both NaHS and MK801 did not show any difference in the per se groups (Fig. 10a-d) .
PSD-95 and SAP-97 Protein Expression
PSD-95 and SAP-97 are scaffolding proteins that have been implicated in the regulation of synapse function. Both the synapse markers PSD-95 and SAP-97 were Fig. 4 downregulated in the hippocampus of Hcy-injected mouse brain. Conversely, the expression of PSD-95 and SAP-97 was restored by NaHS and MK801 treatments. No difference was found in the expression pattern of PSD-95 and SAP-97 in NaHS and MK801 per se treatment groups (Fig. 11a-d) .
Immunohistochemistry of MMP-9 and SAP-97
Immunohistochemistry analysis showed increased expression of MMP-9 and decreased expression of SAP-97 in Hcy (IC) injected mouse brain. Further, NaHS and MK801 treatment significantly improved the expression of MMP-9 and SAP-97. No difference was observed with NaHS and MK801 per se treatments ( Fig. 12a and b) .
SNAP-25, Synaptophysin, and PSD-95 mRNA Expression
In RT-PCR study, we found a significant decrease in synaptosomal-associated protein 25 (SNAP-25), synaptophysin, and PSD-95 expression in Hcy-injected # p < 0.05 indicates significant difference between homocysteine (Hcy) versus NaHS and MK801 treatment. e Representative gelatin zymography images of MMP-9 and MMP-2 gelatinolytic activities in different groups of mice. Here, 1 aCSF, 2 Hcy, 3 NaHS per se, 4 Hcy+NaHS, 5 MK801 per se, and 6 Hcy+MK801. Lower images showing the data for the SDS-PAGE of protein extracts isolated from respective groups of mice. f Bar graph showing the gelatinolyic activity of MMP-2 and MMP-9 in different groups of mice. *p <0.05 indicates significant difference between control versus Hcy (IC) treatment.
# p < 0.05 indicates significant difference between homocysteine (Hcy) versus NaHS and MK801 treatment mouse brain hippocampus. Interestingly, treatment with NaHS and MK801 significantly restored the synapse as evidenced by the increased expression of SNAP-25, synaptophysin, and PSD-95 in the hippocampus, indicating the potential protective effect of H 2 S over the altered synapse function (Fig. 13a, b) .
Discussion
Increased plasma homocysteine (Hcy) levels are a known risk factor for cerebrovascular disease and have been reported in association with cognitive impairment [23] . Reports suggested that high homocysteine levels also affect blood flow # p <0.05 indicates significant difference between homocysteine (Hcy) versus NaHS and MK801 treatment through vessels. Moreover, decreased CBF is associated with cognitive impairment and AD as well as other types of dementia [24, 25] . Previous reports also suggested the relationship between CBF and brain function by showing that an increase in CBF is beneficial for cognitive function [26, 27] . Concurrent with the above study, we observed a significant decrease # p < 0.05 indicates significant difference between homocysteine (Hcy) versus NaHS and MK801 treatment in CBF and impaired memory function in Hcy-injected mice brain. Treatment with NaHS and MK801 significantly improved CBF and memory functions in our study. Protection offered by NaHS and MK801 may be due to increased CBF and improved synaptic plasticity.
Moreover, our results also pointed out relationships and interactions between the NMDA receptor and H 2 S, as we observed protection from both therapeutic agents assumingly mitigated by their effects on the NMDAR. To further confirm the relationship of H 2 S and NMDA-R1, we estimated the NR1 expression in different experimental groups. Interestingly, we found that NaHS and MK801significantly ameliorate increased NR1 expression in Hcy-injected mice. These results strongly suggest the interaction between hydrogen sulfide and NMDA receptor and provide a plausible protective mechanism of H 2 S. On the other hand, we also found that a decreased expression of H 2 S metabolizing enzyme CBS and CSE in mice hippocampus region indicates the low production of H 2 S. Further treatment with MK801 and NaHS significantly ameliorates the CBS and CSE expression.
Previous reports have shown that the alteration of microvascular permeability and disruption of the BBB are detected in the brains of AD subjects and is one of the major events of AD [28] . Concurrent with this reports, we also found that intracerebral injection of Hcy caused increased BSA-FITC leakage, which indicates BBB disruption and increased microvascular permeability. Further, NaHS and MK801 significantly inhibited BSA-FITC leakage, which shows the potential of H 2 S in maintaining microvascular permeability (preventing BBB disruption). Kook et al. [29] reported that perturbed intracellular Ca 2+ homeostasis and BBB damage has implication in the pathogenesis of AD. Disturbed Ca 2+ homeostasis can also affect synaptic plasticity. In agreement with these reports, we also observed increased synaptosomal Ca 2+ levels, indicating excitotoxicity and altered synapse function in Hcy-treated groups; interestingly, NaHS and MK801 treatment significantly alleviated the Ca 2+ influx and thus maintains synapse function. This result further indicates the role of the NMDA receptor in BBB disruption and protective role of H 2 S in e BBB disruption during HHcy mouse brain. Earlier reports suggest that MMPs may be involved in a variety of cellular functions in the brain depending on the cell type involved, and upregulation of MMP-9 may contribute to the pathogenesis of neurodegenerative disorders [30, 31] . Moreover, synapse remodeling induced by MMPs can be blocked by the NMDAR antagonist MK801, indicating the role of NMDAR in synapse remodeling. Nagy et al. [17] suggested the role of MMP-9 in learning and memory. We also found increased levels of MMP-2 and MMP-9 expression as well as increased MMP-9 activity in the hippocampus of Hcyinjected mouse brain. Further, treatment with NaHS and MK801 reduces MMP-2 and MMP-9 expression as well as their activity in the hippocampus, indicating that MMPs are associated with NMDAR activity within the memory center.
Increased MMPs expression leads to disruption of TJ proteins by their natural degradation activity. The BBB permeability depends on the TJ proteins that are present between the endothelial cells of the brain capillaries, which provide a secure environment for the brain and astrocytes [32] . Claudin-5 is the major TJ protein involved in the maintenance of BBB Fig. 10 a PCR and integrity. Our result showed decreased expression of claudin-5 in an Hcy-injected mouse brain, which indicates that BBB integrity was disrupted; however, BBB integrity was restored by NaHS and MK801 treatments. Loss of BBB integrity is associated with increased vascular inflammation in cerebrovascular disease. ICAM-1 expression is restricted to vascular endothelial cells [33] and can be overexpressed in a variety of cells, including neurons, under inflammatory conditions. Indirect evidence from other studies also suggests that high level of ICAM-1 expression in brain tissues is linked with AD and stroke [34] . In accordance with the above reports, Hcy also induced ICAM-1 expression in the mouse hippocampus. Interestingly, overexpression of ICAM-1 was mitigated by NaHS and MK801 treatment. We also checked the expression of astrocyte proteins, which has been extensively associated with inflammation and nutritional equilibrium in neurons. Astrocyte activation is usually associated with synapse dysfunction in pathological conditions of the brain [35] . In our experiments, we found increased expression of GFAP in Hcyinjected mouse brain, which strongly indicates astrocyte activation. To confirm this increase, we performed immunohistochemistry of astrocytes by GFAP and VE-cadherin (an adherence junction protein associated with blood vessels). We found that an increased level of GFAP and decreased level of VE-cadherin protein indicate an association of astrocyte activation with vascular dysfunction. Further, to investigate the correlation of astrocytes with synaptic function and memory, we estimated the pre-and postsynapse markers (synaptophysin, SNAP-25, SAP-97, PSD-95, and MAP-2) and BDNF in the hippocampal tissues. Neurite markers MAP-2 and PSD-95 were associated with synaptic transmission and synaptic plasticity and also maintain synaptogenesis [35, 36] , while SAP-97 exhibits protein interactions and localization of synaptic, presynaptic, and dendritic proteins. These synapse proteins are extensively involved in maintaining neuronal function and synapse function. Similar to vascular inflammation, synaptic dysfunction is also believed to play an important role in the pathogenesis of AD [37] , and the altered intensity of the synaptic proteins may underlie memory impairment [38] . Other reports reinforce that changes in synapse function are central to AD progression and the loss of synaptic plasticity occurring in the learning and memory process [39, 40] . To check the synaptic changes in Hcy-induced altered learning and memory processes, we checked the expression of synaptic proteins and mRNA expression in the different groups of treatment. In agreement with the previously mentioned reports, we also found a significant decrease in synaptophysin, SNAP-25, SAP-97, PSD-95, MAP-2, and BDNF levels indicating synaptic changes within the neurons. These data clearly demonstrate that Hcy leads to synaptic remodeling in the hippocampus. Treatment with NaHS and MK801 significantly ameliorates the level of synaptophysin, SNAP-25, SAP-97, PSD-95, MAP-2, and BDNF in the mouse hippocampus. Thus, our present study clearly indicates the therapeutic potential of H 2 S on synaptic remodeling. Additionally, these data may be critical to better understand the role of MMPs in neurovascular injury in hyperhomocysteinemia. However, more detailed studies using this model may be warranted to more closely simulate the clinical scenario in cerebrovascular disease such as Alzheimer's and stroke.
